STAT | A decade of reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

May 31, 2026

STAT Plus: A standing ovation for RevMed, and caution for Akeso
May 31, 2026

Ultra-low doses could bring costly cancer treatments to more patients in poorer countries
May 30, 2026

STAT Plus: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA
May 30, 2026

STAT Plus: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur says
May 29, 2026

STAT Plus: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
May 29, 2026

STAT Plus: Trump administration seeks to overhaul federal grantmaking process, alarming researchers

Test your knowledge with our now weekday mini crossword

Play the STAT Mini

The Deadliest Drug: America's alcohol epidemic hiding in plain sight

Read the series

STAT Plus: Practice-changing results reported for Revolution Medicines pancreatic cancer drug

In one of the deadliest cancers, daraxonrasib nearly doubled survival time compared to standard chemotherapy, researchers report at ASCO.

Biotech May 31, 2026

STAT Plus: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer

Biotech May 31, 2026

STAT Plus: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

Politics May 30, 2026

STAT Plus: As Ebola outbreak grows, Trump administration veers from previous government playbook

Biotech May 30, 2026

STAT Plus: Revolution Medicines starts shipping experimental pancreatic cancer drug

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: Revolution Medicines starts shipping experimental pancreatic cancer drug

STAT Plus: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds

STAT Plus: As Ebola outbreak grows, Trump administration veers from previous government playbook

STAT Plus: Trump administration seeks to overhaul federal grantmaking process, alarming researchers

STAT Plus: Practice-changing results reported for Revolution Medicines pancreatic cancer drug

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

ASCO 2026: The STAT Recap

Virtual

A virtual recap of ASCO 2026 — highlighting the latest breakthroughs, industry news, and key moments from this year’s event.

Changing Innovation Paradigms — A Navigator’s Guide

Virtual

2026 STAT Summit

Boston, MA

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

Chaotic and politicized: Inside the FDA under Trump

$49

Explore how turmoil and political pressure have destabilized the agency with mass layoffs, rapid staff departures, and a revolving door of leadership.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

A weekly interview show featuring the most interesting people and ideas in medicine.

Color Code

Enjoy the archives of Color Code, our podcast on racial inequities in American health care.

More From STAT

View upcoming events Play the STAT Mini Crossword Explore trackers Download our latest Report Listen to STAT podcasts

More Stories

Biotech May 31, 2026

STAT Plus: A standing ovation for RevMed, and caution for Akeso

Pharma May 31, 2026

Ultra-low doses could bring costly cancer treatments to more patients in poorer countries

Biotech May 30, 2026

STAT Plus: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA

Biotech May 30, 2026

STAT Plus: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur says

Health May 29, 2026

STAT Plus: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer

Politics May 29, 2026

STAT Plus: Trump administration seeks to overhaul federal grantmaking process, alarming researchers

Health May 29, 2026

Kenya court suspends U.S. plan for Ebola quarantine facility for Americans

Exclusive May 29, 2026

STAT Plus: Massachusetts sues UnitedHealth, alleging fraud in state’s Medicaid plans for seniors

Health May 29, 2026

STAT Plus: The woman behind the world’s biggest longevity competition

First Opinion May 29, 2026

I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’

Health May 28, 2026

STAT Plus: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress

The Readout LOUD May 28, 2026

Biotech exec Jeremy Levin on the industry’s strategic turning point

May 29, 2026

STAT Plus: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more

The Readout May 29, 2026

STAT Plus: Allogene CEO David Chang stepping down

Pharmalot May 29, 2026

STAT Plus: Up and down the ladder: The latest comings and goings

Biotech May 28, 2026

STAT Plus: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at risk

D.C. Diagnosis May 28, 2026

STAT Plus: Trump’s pharma deals get tested

Health Tech Newsletter May 28, 2026

STAT Plus: Oura brings rings to the cuffless blood pressure party

First Opinion May 29, 2026

I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’

First Opinion May 28, 2026

Ebola at the World Cup? Here’s what we should actually worry about

Adam's Biotech Scorecard May 28, 2026

STAT Plus: An ASCO preview: What to watch for at cancer research’s big meeting

First Opinion May 27, 2026

MIT president: Why so many optimistic scientists are losing heart

First Opinion May 27, 2026

It’s the end of science as we know it, and I feel fine

First Opinion Podcast May 27, 2026

The patients demanding unvaccinated blood transfusions

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

How America’s alcohol epidemic is hiding in plain sight

By STAT Staff

STAT Plus: The China question is tearing biotech apart

By Damian Garde

STAT Plus: Dark times ahead at the FDA

By Paul Knoepfler

Trump’s cuts to foreign aid are undermining the Ebola response, insiders say

By Daniel Payne

PCOS’s new name is PMOS, a small letter change that required a big scientific process

By Annalisa Merelli

Animal skin disease confirmed in clusters of European men who have sex with men

By Helen Branswell

STAT Plus: Five years after disaster, a rare disease community gets new chance at treatment

Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin with

By Andrew Joseph

STAT Plus: An AI biotech CEO sets the record straight on AI drug development hype

Biotech May 26, 2026

STAT Plus: An AI biotech CEO sets the record straight on AI drug development hype

Biotech May 22, 2026

STAT Plus: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion

Biotech May 21, 2026

STAT Plus: Closely watched experimental Parkinson’s drug fails key clinical trial

STAT Plus: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more

Pharmalot May 28, 2026

STAT Plus: Pharmalittle: We’re reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more

Pharmalot May 27, 2026

STAT Plus: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more

Pharmalot May 26, 2026

STAT Plus: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more

STAT Plus: Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show

Health May 28, 2026

STAT Plus: Experimental hepatitis B treatment was a ‘functional cure’ for nearly 1 in 5, new data show

Health May 27, 2026

STAT Plus: Heart patch engineered from stem cells revved up weakened hearts

Health May 27, 2026

STAT Plus: ‘Are we just going to give up and die like every other generation?’

STAT Plus: Trump’s drug-pricing deals set to be tested by new product launches

Politics May 28, 2026

STAT Plus: Trump’s drug-pricing deals set to be tested by new product launches

Politics May 22, 2026

STAT Plus: Congress slashed Medicaid funding to providers. The Trump administration wants to cut even further

Politics May 22, 2026

A federal office of men’s health has never been closer, yet it’s likely still years away

Video

Senate committee questions NIH director on 2027 budget

Why isn’t alcohol seen as a public health emergency?

Why we left the FDA: Six former officials share their stories

Psychedelics get a boost from the White House

STAT Plus: Blood pressure tech floods the market after FDA relaxes wearables oversight

Health tech May 28, 2026

STAT Plus: Blood pressure tech floods the market after FDA relaxes wearables oversight

Health tech May 27, 2026

STAT Plus: How Stanford patients help expose ‘fault lines’ in health AI adoption

Health tech May 21, 2026

STAT Plus: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature

STAT Plus: 3 burning questions senators had for the NIH director

In the Lab May 21, 2026

STAT Plus: 3 burning questions senators had for the NIH director

In the Lab May 7, 2026

Fraudulent citations, blamed on AI hallucinations, are becoming more common in research papers

In the Lab May 7, 2026

Science is becoming less disruptive. Is an aging workforce to blame?

STAT Plus: Dana-Farber CEO talks untangling from Mass General Brigham and building new cancer hospital

Hospitals April 14, 2026

STAT Plus: Dana-Farber CEO talks untangling from Mass General Brigham and building new cancer hospital

Hospitals March 13, 2026

STAT Plus: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality

Hospitals March 10, 2026

STAT Plus: After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again

STAT Plus: Elevance executive ordered to testify in Medicare Advantage fraud case

Insurance May 21, 2026

STAT Plus: Elevance executive ordered to testify in Medicare Advantage fraud case

Insurance May 18, 2026

STAT Plus: Trump’s CMS to allow skimpier plans on ACA exchanges

Insurance April 30, 2026

STAT Plus: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case

Podcasts

The patients demanding unvaccinated blood transfusions

Guarding biotech from China and big bets in longevity

The rise of perimenopause misinformation

Makary’s departure and Cassidy’s tenuous Senate seat